Peter Gray, Director at Jazz Pharmaceuticals plc (JAZZ), sold 8,000 shares at $158.00 ($1.3M) on 2022-08-18, disclosed to the SEC on 2022-08-22.
Seasonal sale ($1.3M) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2021-08-10 | $418K | — | Filing → |
| JAZZ | SELL | 2019-08-12 | $214K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $253K | — | Filing → |